Cargando…

Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer

BACKGROUND: The unfolded protein response (UPR) served as a vital role in the progression of tumors, but the molecule mechanisms of UPR in bladder cancer (BLCA) have been not fully investigated. METHODS: We identified differentially expressed unfolded protein response-related genes (UPRRGs) between...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ke, Xiaoqiang, Liu, Deng, Wen, Wang, Gongxian, Fu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686253/
https://www.ncbi.nlm.nih.gov/pubmed/34930465
http://dx.doi.org/10.1186/s40246-021-00372-x
_version_ 1784617978896056320
author Zhu, Ke
Xiaoqiang, Liu
Deng, Wen
Wang, Gongxian
Fu, Bin
author_facet Zhu, Ke
Xiaoqiang, Liu
Deng, Wen
Wang, Gongxian
Fu, Bin
author_sort Zhu, Ke
collection PubMed
description BACKGROUND: The unfolded protein response (UPR) served as a vital role in the progression of tumors, but the molecule mechanisms of UPR in bladder cancer (BLCA) have been not fully investigated. METHODS: We identified differentially expressed unfolded protein response-related genes (UPRRGs) between BLCA samples and normal bladder samples in the Cancer Genome Atlas (TCGA) database. Univariate Cox analysis and the least absolute shrinkage and selection operator penalized Cox regression analysis were used to construct a prognostic signature in the TCGA set. We implemented the validation of the prognostic signature in GSE13507 from the Gene Expression Omnibus database. The ESTIMATE, CIBERSORT, and ssGSEA algorithms were used to explore the correlation between the prognostic signature and immune cells infiltration as well as key immune checkpoints (PD-1, PD-L1, CTLA-4, and HAVCR2). GDSC database analyses were conducted to investigate the chemotherapy sensitivity among different groups. GSEA analysis was used to explore the potential mechanisms of UPR-based signature. RESULTS: A prognostic signature comprising of seven genes (CALR, CRYAB, DNAJB4, KDELR3, CREB3L3, HSPB6, and FBXO6) was constructed to predict the outcome of BLCA. Based on the UPRRGs signature, the patients with BLCA could be classified into low-risk groups and high-risk groups. Patients with BLCA in the low-risk groups showed the more favorable outcomes than those in the high-risk groups, which was verified in GSE13507 set. This signature could serve as an autocephalous prognostic factor in BLCA. A nomogram based on risk score and clinical characteristics was established to predict the over survival of BLCA patients. Furthermore, the signature was closely related to immune checkpoints (PD-L1, CTLA-4, and HAVCR2) and immune cells infiltration including CD8(+) T cells, follicular helper T cells, activated dendritic cells, and M2 macrophages. GSEA analysis indicated that immune and carcinogenic pathways were enriched in high-risk group. CONCLUSIONS: We identified a novel unfolded protein response-related gene signature which could predict the over survival, immune microenvironment, and chemotherapy response of patients with bladder cancer.
format Online
Article
Text
id pubmed-8686253
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86862532021-12-20 Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer Zhu, Ke Xiaoqiang, Liu Deng, Wen Wang, Gongxian Fu, Bin Hum Genomics Primary Research BACKGROUND: The unfolded protein response (UPR) served as a vital role in the progression of tumors, but the molecule mechanisms of UPR in bladder cancer (BLCA) have been not fully investigated. METHODS: We identified differentially expressed unfolded protein response-related genes (UPRRGs) between BLCA samples and normal bladder samples in the Cancer Genome Atlas (TCGA) database. Univariate Cox analysis and the least absolute shrinkage and selection operator penalized Cox regression analysis were used to construct a prognostic signature in the TCGA set. We implemented the validation of the prognostic signature in GSE13507 from the Gene Expression Omnibus database. The ESTIMATE, CIBERSORT, and ssGSEA algorithms were used to explore the correlation between the prognostic signature and immune cells infiltration as well as key immune checkpoints (PD-1, PD-L1, CTLA-4, and HAVCR2). GDSC database analyses were conducted to investigate the chemotherapy sensitivity among different groups. GSEA analysis was used to explore the potential mechanisms of UPR-based signature. RESULTS: A prognostic signature comprising of seven genes (CALR, CRYAB, DNAJB4, KDELR3, CREB3L3, HSPB6, and FBXO6) was constructed to predict the outcome of BLCA. Based on the UPRRGs signature, the patients with BLCA could be classified into low-risk groups and high-risk groups. Patients with BLCA in the low-risk groups showed the more favorable outcomes than those in the high-risk groups, which was verified in GSE13507 set. This signature could serve as an autocephalous prognostic factor in BLCA. A nomogram based on risk score and clinical characteristics was established to predict the over survival of BLCA patients. Furthermore, the signature was closely related to immune checkpoints (PD-L1, CTLA-4, and HAVCR2) and immune cells infiltration including CD8(+) T cells, follicular helper T cells, activated dendritic cells, and M2 macrophages. GSEA analysis indicated that immune and carcinogenic pathways were enriched in high-risk group. CONCLUSIONS: We identified a novel unfolded protein response-related gene signature which could predict the over survival, immune microenvironment, and chemotherapy response of patients with bladder cancer. BioMed Central 2021-12-20 /pmc/articles/PMC8686253/ /pubmed/34930465 http://dx.doi.org/10.1186/s40246-021-00372-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Zhu, Ke
Xiaoqiang, Liu
Deng, Wen
Wang, Gongxian
Fu, Bin
Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
title Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
title_full Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
title_fullStr Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
title_full_unstemmed Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
title_short Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
title_sort identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686253/
https://www.ncbi.nlm.nih.gov/pubmed/34930465
http://dx.doi.org/10.1186/s40246-021-00372-x
work_keys_str_mv AT zhuke identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer
AT xiaoqiangliu identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer
AT dengwen identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer
AT wanggongxian identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer
AT fubin identificationofanovelsignaturebasedonunfoldedproteinresponserelatedgeneforpredictingprognosisinbladdercancer